Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells

This publication has 55 references indexed in Scilit:

• Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
  Blood, 2006
• Uroporphyrinogen III Synthase Knock-In Mice Have the Human Congenital Erythropoietic Porphyria Phenotype, Including the Characteristic Light-Induced Cutaneous Lesions
  American Journal of Human Genetics, 2006
• Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease)
  European Journal of Pediatrics, 2004
• Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
  Gene Therapy, 2004
• Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without Preselection
  Molecular Therapy, 2001
• Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
  Gene Therapy, 2001
• Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature
  Bone Marrow Transplantation, 2001
• Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphyria
  Hepatology, 2000
• Congenital erythropoietic porphyria
  Published by Elsevier ,1997
• Correction of congenital erythropoietic porphyria by bone marrow transplantation
  The Journal of Pediatrics, 1996